Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing mitoxantrone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mitoxantrone (substance) |
Inferred relationship |
Some |
1 |
Mitozantrone poisoning (disorder) |
Causative agent (attribute) |
True |
Mitoxantrone (substance) |
Inferred relationship |
Some |
1 |
Accidental mitozantrone poisoning (disorder) |
Causative agent (attribute) |
False |
Mitoxantrone (substance) |
Inferred relationship |
Some |
|
Intentional mitozantrone poisoning (disorder) |
Causative agent (attribute) |
False |
Mitoxantrone (substance) |
Inferred relationship |
Some |
|
Mitozantrone poisoning of undetermined intent |
Causative agent (attribute) |
False |
Mitoxantrone (substance) |
Inferred relationship |
Some |
1 |
Mitozantrone adverse reaction (disorder) |
Causative agent (attribute) |
True |
Mitoxantrone (substance) |
Inferred relationship |
Some |
1 |
Allergy to mitoxantrone |
Causative agent (attribute) |
False |
Mitoxantrone (substance) |
Inferred relationship |
Some |
|
Mitozantrone overdose (disorder) |
Causative agent (attribute) |
True |
Mitoxantrone (substance) |
Inferred relationship |
Some |
1 |
Accidental mitozantrone overdose (disorder) |
Causative agent (attribute) |
True |
Mitoxantrone (substance) |
Inferred relationship |
Some |
1 |
Intentional mitozantrone overdose (disorder) |
Causative agent (attribute) |
True |
Mitoxantrone (substance) |
Inferred relationship |
Some |
1 |
Mitozantrone overdose of undetermined intent |
Causative agent (attribute) |
False |
Mitoxantrone (substance) |
Inferred relationship |
Some |
1 |
Mitozantrone 2mg/mL infusion concentrate 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mitoxantrone (substance) |
Inferred relationship |
Some |
|
Mitozantrone 2mg/mL injection concentrate 12.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mitoxantrone (substance) |
Inferred relationship |
Some |
|
Mitozantrone 2mg/mL injection concentrate 15mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mitoxantrone (substance) |
Inferred relationship |
Some |
|
Mitozantrone 2mg/mL infusion solution 22.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mitoxantrone (substance) |
Inferred relationship |
Some |
|
Mitozantrone 2mg/mL infusion solution 45mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mitoxantrone (substance) |
Inferred relationship |
Some |
|
Mitoxantrone hydrochloride 1mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mitoxantrone (substance) |
Inferred relationship |
Some |
|
Mitoxantrone hydrochloride 2mg/mL infusion concentrate 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mitoxantrone (substance) |
Inferred relationship |
Some |
|
Mitoxantrone hydrochloride (substance) |
Is a |
False |
Mitoxantrone (substance) |
Inferred relationship |
Some |
|
Mitozantrone 2mg/mL infusion concentrate 15mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mitoxantrone (substance) |
Inferred relationship |
Some |
|
Accidental mitozantrone poisoning (disorder) |
Causative agent (attribute) |
True |
Mitoxantrone (substance) |
Inferred relationship |
Some |
1 |
Intentional mitozantrone poisoning (disorder) |
Causative agent (attribute) |
True |
Mitoxantrone (substance) |
Inferred relationship |
Some |
1 |
Mitozantrone 2mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mitoxantrone (substance) |
Inferred relationship |
Some |
|
Allergy to mitoxantrone |
Causative agent (attribute) |
True |
Mitoxantrone (substance) |
Inferred relationship |
Some |
1 |
Mitoxantrone hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Mitoxantrone (substance) |
Inferred relationship |
Some |
|
Mitoxantrone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mitoxantrone (substance) |
Inferred relationship |
Some |
1 |
Mitoxantrone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mitoxantrone (substance) |
Inferred relationship |
Some |
1 |
Product containing mitoxantrone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mitoxantrone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mitoxantrone (as mitoxantrone hydrochloride) 2 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mitoxantrone (substance) |
Inferred relationship |
Some |
1 |